Literature DB >> 17009014

Activation of MKK4 (SEK1), JNK, and c-Jun in labial salivary infiltrating T cells in patients with Sjögren's syndrome.

Kazutaka Soejima1, Hideki Nakamura, Mami Tamai, Atsushi Kawakami, Katsumi Eguchi.   

Abstract

We wanted to determine via immunohistochemistry, whether or not c-Jun NH2-terminal kinase (JNK) cascade is activated in labial salivary infiltrating T cells in patients with Sjögren's syndrome (SS). Six patients with primary SS were selected for this study. Phosphorylation of mitogen-activated protein kinase (MAPK) kinase 4 (MKK4) (SEK1), JNK, and c-Jun in salivary infiltrating T cells was studied using immunohistochemistry assay, including mirror section technique. Phosphorylated forms of MKK4, JNK, and c-Jun were detected in salivary infiltrating mononuclear cells. Expression of phosphorylated JNK was found in both CD4+ T cells and CD8+ T cells. Moreover, co-expression of phosphorylated JNK and c-Jun was demonstrated in the mirror sections. The results of this study suggest that the JNK cascade is activated in salivary infiltrating CD4+ T cells and CD8+ T cells in SS patients, which appears to contribute to the inflammatory salivary microenvironment of SS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17009014     DOI: 10.1007/s00296-006-0229-x

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  16 in total

Review 1.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

2.  Expression of the MAPK kinases MKK-4 and MKK-7 in rheumatoid arthritis and their role as key regulators of JNK.

Authors:  Monisha Sundarrajan; David L Boyle; Martine Chabaud-Riou; Deepa Hammaker; Gary S Firestein
Journal:  Arthritis Rheum       Date:  2003-09

3.  IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation.

Authors:  F Mercurio; H Zhu; B W Murray; A Shevchenko; B L Bennett; J Li; D B Young; M Barbosa; M Mann; A Manning; A Rao
Journal:  Science       Date:  1997-10-31       Impact factor: 47.728

Review 4.  Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases.

Authors:  Gary L Johnson; Razvan Lapadat
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

5.  Functional expression of a costimulatory B7.2 (CD86) protein on human salivary gland epithelial cells that interacts with the CD28 receptor, but has reduced binding to CTLA4.

Authors:  E K Kapsogeorgou; H M Moutsopoulos; M N Manoussakis
Journal:  J Immunol       Date:  2001-03-01       Impact factor: 5.422

6.  Expression of mitogen activated protein kinases in labial salivary glands of patients with Sjögren's syndrome.

Authors:  H Nakamura; A Kawakami; S Yamasaki; Y Kawabe; T Nakamura; K Eguchi
Journal:  Ann Rheum Dis       Date:  1999-06       Impact factor: 19.103

7.  JSAP1, a novel jun N-terminal protein kinase (JNK)-binding protein that functions as a Scaffold factor in the JNK signaling pathway.

Authors:  M Ito; K Yoshioka; M Akechi; S Yamashita; N Takamatsu; K Sugiyama; M Hibi; Y Nakabeppu; T Shiba; K I Yamamoto
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

8.  Synergistic activation of SAPK1/JNK1 by two MAP kinase kinases in vitro.

Authors:  S Lawler; Y Fleming; M Goedert; P Cohen
Journal:  Curr Biol       Date:  1998 Dec 17-31       Impact factor: 10.834

Review 9.  Involvement of apoptotic cell death in autoimmune diseases.

Authors:  Atsushi Kawakami; Katsumi Eguchi
Journal:  Med Electron Microsc       Date:  2002-03

10.  Docking interactions in the c-Jun N-terminal kinase pathway.

Authors:  Lorraine M Mooney; Alan J Whitmarsh
Journal:  J Biol Chem       Date:  2003-12-29       Impact factor: 5.157

View more
  5 in total

1.  Effect of mesenchymal stem cells on Sjögren-like mice and the microRNA expression profiles of splenic CD4+ T cells.

Authors:  Guang-Feng Ruan; Ling Zheng; Jia-Shu Huang; Wan-Xue Huang; Bang-Dong Gong; Xing-Xing Fang; Xiao-Yu Zhang; Jian-Ping Tang
Journal:  Exp Ther Med       Date:  2017-04-06       Impact factor: 2.447

2.  Increased risk of bisphosphonate-related osteonecrosis of the jaw in patients with Sjögren's syndrome: nationwide population-based cohort study.

Authors:  Min-Tser Liao; Wu-Chien Chien; Jen-Chun Wang; Chi-Hsiang Chung; Shi-Jye Chu; Shih-Hung Tsai
Journal:  BMJ Open       Date:  2019-02-13       Impact factor: 2.692

3.  MALT1 regulates Th2 and Th17 differentiation via NF-κB and JNK pathways, as well as correlates with disease activity and treatment outcome in rheumatoid arthritis.

Authors:  Qiubo Wang; Yapeng Wang; Qingyang Liu; Ying Chu; Rui Mi; Fengying Jiang; Jingjing Zhao; Kelong Hu; Ran Luo; Yufeng Feng; Harrison Lee; Dong Zhou; Jingyi Mi; Ruoyu Deng
Journal:  Front Immunol       Date:  2022-07-28       Impact factor: 8.786

Review 4.  CD8+ T Cell Phenotype and Function in Childhood and Adult-Onset Connective Tissue Disease.

Authors:  Anna Radziszewska; Zachary Moulder; Elizabeth C Jury; Coziana Ciurtin
Journal:  Int J Mol Sci       Date:  2022-09-28       Impact factor: 6.208

5.  Increased risk of aortic aneurysm and dissection in patients with Sjögren's syndrome: a nationwide population-based cohort study in Taiwan.

Authors:  Yi-Da Tsai; Wu-Chien Chien; Shih-Hung Tsai; Chi-Hsiang Chung; Shi-Jye Chu; Sy-Jou Chen; Wen-I Liao; Chih-Jen Yang; Min-Tser Liao; Jen-Chun Wang
Journal:  BMJ Open       Date:  2018-09-21       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.